New Obesity Pill
The Sydney Morning Herald reported today that early next year, the French pharmaceutical company Sanofi-Aventis will start selling a drug designed to induce the “anti-munchies”. Rimonabant taps into the brain circuits by and turns them off. If what has been made public from the clinical trials is anything to go by, Rimonabant has almost miraculous powers, helping people to control their appetites and banish many of the metabolic problems associated with being too fat.
Rimonabant blocks CB1 receptors, which appears to reduce the hunger.
